Letters COPD

Drug management of COPD

BMJ 2007; 334 doi: https://doi.org/10.1136/bmj.39191.719352.3A (Published 26 April 2007) Cite this as: BMJ 2007;334:864
  1. Peter D Burrill, specialist pharmaceutical adviser for public health
  1. Derbyshire County Primary Care Trust, Chesterfield S41 7PF
  1. peter.burrill{at}derbyshirecountypct.nhs.uk

    In the second step of prescribing for long term management of chronic obstructive pulmonary disease, McIvor and Little recommend the addition of a long acting β2 agonist (LABA) to a short acting β2 agonist as needed, supplemented by stepwise addition of regular short or long acting anticholinergic inhalers.1 I agree …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe